Karyopharm Therapeutics
KPTI
KPTI
103 hedge funds and large institutions have $306M invested in Karyopharm Therapeutics in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
-5
Holders Change %
-4.63%
% of All Funds
2.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
39
Reduced
30
Closed
18
Calls
$4.59M
Puts
$815K
Net Calls
+$3.77M
Net Calls Change
+$990K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$18.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.6M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$3.86M |
| 4 |
AI
Atom Investors
Austin,
Texas
|
+$2.52M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.31M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$15.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.46M |
| 3 |
Renaissance Technologies
New York
|
-$5.06M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.91M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.97M |
